Samsung Biologics Completes Rockville Facility Buy

Samsung Biologics has completed its acquisition of GSK’s manufacturing facility in Rockville, Maryland. The closed transaction expands Samsung Biologics’ operations into the United States.

The excerpt provided does not include deal value or specific financial terms, but the acquired asset is a biologics manufacturing site in Rockville, supporting Samsung Biologics’ production footprint in the US.